Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Pediatric Cancer Clinical Trials
Pediatric Cancer clinical trials are recruiting across 70 cities. Here are the cities with the most active studies:
Pediatric Cancer Trial Phases
37 research organizations are sponsoring pediatric cancer trials.
About Pediatric Cancer
Pediatric cancers include a wide range of cancers occurring in children and adolescents, with leukemia, brain tumors, and lymphoma being most common. Overall cure rates have improved dramatically to about 80%. Treatment includes chemotherapy, surgery, radiation, and newer immunotherapies.
Clinical trials are advancing new treatments for pediatric cancer. Currently, 75 studies are recruiting a combined 57,047 participants across the United States. Research is being conducted by 37 organizations including St. Jude Children's Research Hospital, Children's Hospital Los Angeles, National Cancer Institute (NCI) and 34 others.
2026 Pediatric Cancer Research Landscape
As of July 2026, the pediatric cancer clinical trial landscape includes 75 actively recruiting studies across 70 cities in the United States. These studies are collectively seeking 57,047 participants, with an average enrollment target of 761 per study.
The research spans multiple phases of development: 24 studies are in NA, 22 studies are in PHASE2, 13 studies are in PHASE1, 4 studies are in PHASE3. The presence of Phase 3 trials indicates that some pediatric cancer treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 37 different organizations, including St. Jude Children's Research Hospital, Children's Hospital Los Angeles, National Cancer Institute (NCI), Memorial Sloan Kettering Cancer Center, Children's Oncology Group, and 32 others. The large number of sponsors reflects significant research interest and investment in pediatric cancer treatment advancement.
Geographically, pediatric cancer trials are most concentrated in Memphis, Tennessee (14 trials); Boston, Massachusetts (14 trials); Birmingham, Alabama (9 trials); Los Angeles, California (8 trials); New York, New York (8 trials) and 7 other cities.
Featured Pediatric Cancer Studies
Highlighted recruiting studies for pediatric cancer, selected by enrollment size and research scope.
Protocol For Collecting Data On Patients With Childhood Cancer
Progress in the development of curative therapy for pediatric malignancies has resulted in increasing numbers of long-term childhood cancer survivors. This protocol is a means to provide continuing review of outcome and late toxicity for all patients actively being treated and previously treated for childhood cancer at St. Jude Children's Research Hospital.
LIFE Cancer Survivorship Database for Pediatric Cancer
The purpose of this study is to develop a mechanism for utilizing the comprehensive clinical database of childhood cancer survivors at Childrens Hospital Los Angeles (CHLA) for research purposes. Using clinical information obtained from follow-up visits of childhood cancer survivors, the database will focus on interventions to improve health status and health-related quality of life in childhood c...
Psychological Benefits of a Normalized Camping Experience for Children With Cancer
Background: * Cancer has an enormous impact on the psychological and social well-being of the family unit. The life-threatening connotations of cancer single out the ill child from his peer/family group as one who is different, and often unable to maintain a normal lifestyle. Physical sequelae of cancer and its treatment accentuate the differences between these children and their normal peers/sib...
Frequently Asked Questions About Pediatric Cancer Clinical Trials
Are there pediatric cancer clinical trials near me?
Yes, there are 75 pediatric cancer clinical trials currently recruiting across 70+ cities in the United States, including Memphis, Tennessee; Boston, Massachusetts; Birmingham, Alabama. Browse the studies above to find one at a location convenient for you.
How do I join a pediatric cancer clinical trial?
To join a pediatric cancer clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are pediatric cancer clinical trials free?
Yes, participation in pediatric cancer clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of pediatric cancer treatments are being studied?
Current pediatric cancer clinical trials are testing a range of approaches across NA (24 studies), PHASE2 (22 studies), PHASE1 (13 studies), PHASE3 (4 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 37 research organizations.
Is it safe to participate in pediatric cancer clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov